TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Läkemedelsgruppen Sverige AB
Closing information (x1000 NOK)
Closing information | 2024/04 | 2023/04 | 2022/04 |
Turnover |
26,546
|
18,412
|
17,277 |
Financial expenses |
46
|
17
|
13 |
Earnings before taxes |
1,753
|
-707
|
761 |
EBITDA |
1,830
|
-652
|
779 |
Total assets |
4,563
|
4,181
|
3,080 |
Current assets |
4,260
|
3,948
|
3,032 |
Current liabilities |
2,789
|
2,298
|
1,713 |
Equity capital |
1,288
|
1,270
|
1,307 |
- share capital |
50
|
52
|
48 |
Employees (average) |
25
|
20
![]() |
20 |
Financial ratios
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Solvency |
28.2%
|
30.4%
|
42.4% |
Turnover per employee |
1,062
|
921
|
864 |
Profit as a percentage of turnover |
6.6%
|
-3.8%
|
4.4% |
Return on assets (ROA) |
39.4%
|
-16.5%
|
25.1% |
Current ratio |
152.7%
|
171.8%
|
177.0% |
Return on equity (ROE) |
136.1%
|
-55.7%
|
58.2% |
Change turnover |
8,692
|
-371
|
713 |
Change turnover % |
49%
|
-2%
|
4% |
Chg. No. of employees |
5
|
0
|
1 |
Chg. No. of employees % |
25%
|
0%
|
5% |
Total value of public sale
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.